172 related articles for article (PubMed ID: 18255349)
1. Patient predictors of esophageal stricture development after photodynamic therapy.
Yachimski P; Puricelli WP; Nishioka NS
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):302-8. PubMed ID: 18255349
[TBL] [Abstract][Full Text] [Related]
2. Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett's esophagus.
Prasad GA; Wang KK; Buttar NS; Wongkeesong LM; Lutzke LS; Borkenhagen LS
Gastrointest Endosc; 2007 Jan; 65(1):60-6. PubMed ID: 17185080
[TBL] [Abstract][Full Text] [Related]
3. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation.
Panjehpour M; Overholt BF; Haydek JM; Lee SG
Am J Gastroenterol; 2000 Sep; 95(9):2177-84. PubMed ID: 11007214
[TBL] [Abstract][Full Text] [Related]
4. Long term efficacy of Photodynamic Therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett's oesophagus.
Gray J; Fullarton GM
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):561-5. PubMed ID: 24284112
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
Foroulis CN; Thorpe JA
Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
[TBL] [Abstract][Full Text] [Related]
7. Patient predictors of histopathologic response after photodynamic therapy of Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.
Yachimski P; Puricelli WP; Nishioka NS
Gastrointest Endosc; 2009 Feb; 69(2):205-12. PubMed ID: 18950764
[TBL] [Abstract][Full Text] [Related]
8. Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia.
Panjehpour M; Overholt BF
Lasers Surg Med; 2006 Jun; 38(5):390-5. PubMed ID: 16788927
[TBL] [Abstract][Full Text] [Related]
9. Changes in esophageal motility after porfimer sodium photodynamic therapy for Barrett's dysplasia and mucosal carcinoma.
Shah AK; Wolfsen HC; Hemminger LL; Shah AA; DeVault KR
Dis Esophagus; 2006; 19(5):335-9. PubMed ID: 16984528
[TBL] [Abstract][Full Text] [Related]
10. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus.
Pacifico RJ; Wang KK; Wongkeesong LM; Buttar NS; Lutzke LS
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):252-7. PubMed ID: 15017665
[TBL] [Abstract][Full Text] [Related]
11. Optimization of light dosimetry for photodynamic therapy of Barrett's esophagus: efficacy vs. incidence of stricture after treatment.
Panjehpour M; Overholt BF; Phan MN; Haydek JM
Gastrointest Endosc; 2005 Jan; 61(1):13-8. PubMed ID: 15672050
[TBL] [Abstract][Full Text] [Related]
12. Pilot study on light dosimetry variables for photodynamic therapy of Barrett's esophagus with high-grade dysplasia.
Gill KR; Wolfsen HC; Preyer NW; Scott MV; Gross SA; Wallace MB; Jones LR
Clin Cancer Res; 2009 Mar; 15(5):1830-6. PubMed ID: 19240171
[TBL] [Abstract][Full Text] [Related]
13. The role of photodynamic therapy in the esophagus.
Gross SA; Wolfsen HC
Gastrointest Endosc Clin N Am; 2010 Jan; 20(1):35-53, vi. PubMed ID: 19951793
[TBL] [Abstract][Full Text] [Related]
14. Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett's esophagus.
Ban S; Mino M; Nishioka NS; Puricelli W; Zukerberg LR; Shimizu M; Lauwers GY
Am J Surg Pathol; 2004 Nov; 28(11):1466-73. PubMed ID: 15489650
[TBL] [Abstract][Full Text] [Related]
15. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study.
Ortner M-; Zumbusch K; Liebetruth J; Ebert B; Fleige B; Dietel M; Lochs H
Endoscopy; 2002 Aug; 34(8):611-6. PubMed ID: 12173080
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy.
Schembre DB; Huang JL; Lin OS; Cantone N; Low DE
Gastrointest Endosc; 2008 Apr; 67(4):595-601. PubMed ID: 18279860
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 expression in esophageal epithelium before and after photodynamic therapy for Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.
Yachimski P; Mino-Kenudson M; Sherwood ME; Puricelli WP; Nishioka NS; Lauwers GY
Virchows Arch; 2011 Dec; 459(6):581-6. PubMed ID: 22081106
[TBL] [Abstract][Full Text] [Related]
18. Buried dysplasia and early adenocarcinoma arising in barrett esophagus after porfimer-photodynamic therapy.
Mino-Kenudson M; Ban S; Ohana M; Puricelli W; Deshpande V; Shimizu M; Nishioka NS; Lauwers GY
Am J Surg Pathol; 2007 Mar; 31(3):403-9. PubMed ID: 17325482
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer.
Keeley SB; Pennathur A; Gooding W; Landreneau RJ; Christie NA; Luketich J
Ann Surg Oncol; 2007 Aug; 14(8):2406-10. PubMed ID: 17534685
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy and endoscopic mucosal resection for Barrett's dysplasia and early esophageal adenocarcinoma.
Wolfsen HC; Hemminger LL; Raimondo M; Woodward TA
South Med J; 2004 Sep; 97(9):827-30. PubMed ID: 15455964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
